May 17, 2021
Monday May 17, 2021, 1-2pm
LDRI Seminar
Prof. Vincent Van Pesch, IoNS and Cliniques Universitaires Saint Luc Brussels, neurologist specialized in multiple sclerosis.
“Multiple Sclerosis in 2021 : recent advances from bench to bedside “
Related publications:
- Absinta M, Lassmann H, Trapp BD. Mechanisms underlying progression in multiple sclerosis. Curr Opin Neurol. 2020 Jun;33(3):277-285. doi: 10.1097/WCO.0000000000000818.
- Perdaens O et al. CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders. Neurol Neuroimmunol Neuroinflamm. 2020 Feb 7;7(2):e673. doi: 10.1212/NXI.0000000000000673.
- Maggi P et al. Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study. Ann Neurol. 2020 Nov;88(5):1034-1042. doi: 10.1002/ana.25877.
- Kuhle J et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. 2019 Mar 5;92(10):e1007-e1015. doi: 10.1212/WNL.0000000000007032.
- Brown JWL et al.; MSBase Study Group. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis. JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588.